DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Han D, Gao S, Valencia K. et al.
A novel nonsense mutation in androgen receptor confers resistance to CYP17 inhibitor treatment in prostate cancer.
Oncotarget 2017;
8: 6796-6808
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.